Financial Daily from THE HINDU group of publications
Tuesday, Aug 10, 2004

News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

Corporate - Sick Units
Industry & Economy - PSU


Rs 115-cr revival plan proposed for Hind Antibiotics

Nithya Subramanian
Ambarish Mukherjee

New Delhi , Aug. 9

The board of ailing Hindustan Antibiotics Ltd has submitted a Rs 115-crore revival package to the Government involving fresh capital infusion and one-time settlement of dues of financial institutions.

The Department of Chemicals and Petrochemicals is currently examining the plan and will finalise its stand by the end of the month, officials said.

"According to the plan submitted to the Government funds would be generated through a mix of fresh infusion of funds by the Ministry, seeking of waiver from financial institutions as well as generating internal funds by selling off surplus land," officials said.

After the department finalises its views on the company's revival plan, it will invite comments from the other Ministries concerned, including the Ministry of Finance. Subsequently, the matter will be referred to the IDBI.

"Only after IDBI, which is the operating agency for this company, approves of the revival package can Hindustan Anitbiotics be brought out of the Board of Industrial and Financial Reconstruction (BIFR) net," sources said.

The Common Minimum Programme (CMP) of the present United Progressive Alliance (UPA) had clearly stated that the Government would try and revive some of the ailing public sector units (PSUs).

In fact, the Finance Minister, Mr P. Chidambaram, had in his Budget speech also stated, "HAL will be given financial support for restructuring."

Earlier, the Minister for Chemicals and Fertilisers, Mr Ram Vilas Paswan, had estimated that the company would need around Rs 70 crore for revival and it already has land worth Rs 40 crore.

Hindustan Antibiotics is one of the oldest PSU companies, which was set up by the first Prime Minister of India, Mr Jawahar Lal Nehru, after he realised that Mahatma Gandhi's wife Kasturba Gandhi died due to non-availability of antibiotics.

Subsequently, the company started making losses and has been under the BIFR fold since March 31, 1997.

The BIFR had invited private companies to bid for the sick unit and Sun Pharmaceuticals had submitted a rehabilitation plan.

With the change in Government policy, the Mumbai-based company decided to pull out of the race.

The success turnaround of HAL will pave the way for other such proposals. The Government recently set up a technical committee for looking into the rehabilitation of Indian Drugs and Pharmaceuticals Ltd.

Hindustan Organics and Chemicals Ltd, another PSU under the Chemicals and Fertilisers Ministry is also in the red.

More Stories on : Sick Units | PSU | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Stories in this Section
Ocimum announces free bioinfo service


Arvind Mills gets shareholder nod to up FII limit to 49%
Natco Pharma launches drug for prostate cancer
Apollo Tyres opens outlet for farmers
ICAI calls for changes in ESOP norms
UB, Shaw Wallace bury the hatchet
More disclosure norms for foreign cos on cards?
CLB clears 248 cases
Service tax case: SC dismisses plea against tribunal order
Assocham against job quota in private sector
Laundry chain White Tiger plans Rs 70-cr expansion
Venkateswara group to set up bird breeding farm in West Bengal
Alps Industries to set up new plant
Universal Cables on diversification path
Rs 115-cr revival plan proposed for Hind Antibiotics
Hearing on SCM closure petition on August 23
Indian Hotels bullish on growth
Sona Koyo may source from Thailand post-FTA
Gujarat Ambuja to set up 1.2 mt facility at Dadri
Reliance Hirma unit to go commercial next year
Better earnings from oil firms seen this quarter
Divi's Labs sees Rs 400-cr turnover
What the CEOs took home



The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2004, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line